ALEXANDER ROBINWEILER P.A.
Prescription History 1336574607
Physician Assistant in Bellevue, WA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ALEXANDER ROBINWEILER P.A., an active Physician Assistant specialist practicing in Bellevue, WA. Our medical registry currently tracks 30 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 660 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 41 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other WA PrescribersVs. WA Avg |
|---|---|---|---|
| Anastrozole | 41 | $13.45▼ below WA avg | ▼ Less than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 41 Medicare prescriptions for Anastrozole, about 64% of the volume of the typical Washington prescriber of this medication (63.7). Medicare paid an average of $13.45 per fill, versus $17.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 105.2 30-Day Fills standardized to 30-day supplies 3,156 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 41 | $8.80▼ below WA avg | ≈ Typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 41 Medicare prescriptions for Prochlorperazine Maleate, about 1.2 times the volume of the typical Washington prescriber of this medication (33.6). Medicare paid an average of $8.80 per fill, versus $14.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 41 30-Day Fills standardized to 30-day supplies 274 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 40 | $19.22 | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 40 Medicare prescriptions for Dexamethasone, about 1.2 times the volume of the typical Washington prescriber of this medication (34.2). Medicare paid an average of $19.22 per fill, versus $12.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51 30-Day Fills standardized to 30-day supplies 1,283 Days of Medication total across all patients in 2024 | |||
| TagrissoOsimertinib Mesylate | 37 | $18,540.15 | ▲ More than typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. An EGFR tyrosine kinase inhibitor. In 2024, this provider wrote 37 Medicare prescriptions for Tagrisso, about 1.3 times the volume of the typical Washington prescriber of this medication (28.1). Medicare paid an average of $18,540.15 per fill, versus $16,984.56 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2024 | |||
| ImbruvicaIbrutinib | 37 | $18,436.22 | ▲ More than typical |
About Imbruvica: This medication is used to treat certain cancers (such as chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). A Btk protein inhibitor. In 2024, this provider wrote 37 Medicare prescriptions for Imbruvica, about 1.5 times the volume of the typical Washington prescriber of this medication (24.3). Medicare paid an average of $18,436.22 per fill, versus $16,282.74 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,058 Days of Medication total across all patients in 2024 | |||
| Hydroxyurea | 35 | $13.86▼ below WA avg | ≈ Typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2024, this provider wrote 35 Medicare prescriptions for Hydroxyurea, about the same volume as the typical Washington prescriber of this medication (33.1). Medicare paid an average of $13.86 per fill, versus $25.87 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,430 Days of Medication total across all patients in 2024 | |||
| Prednisone | 34 | $5.84 | ≈ Typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 34 Medicare prescriptions for Prednisone, about 90% of the volume of the typical Washington prescriber of this medication (38). Medicare paid an average of $5.84 per fill, versus $5.30 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,204 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 32 | $7.10▼ below WA avg | ≈ Typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 32 Medicare prescriptions for Ondansetron Hcl, about the same volume as the typical Washington prescriber of this medication (29). Medicare paid an average of $7.10 per fill, versus $11.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 32 30-Day Fills standardized to 30-day supplies 354 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 31 | $14.66▼ below WA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 31 Medicare prescriptions for Gabapentin, about half the volume of the typical Washington prescriber of this medication (72.3). Medicare paid an average of $14.66 per fill, versus $19.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 43 30-Day Fills standardized to 30-day supplies 1,290 Days of Medication total across all patients in 2024 | |||
| BrukinsaZanubrutinib | 31 | $15,027.17 | ▲ More than typical |
About Brukinsa: This medication is used to treat certain cancers (mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma). Show more ▾ Zanubrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. A Bruton tyrosine kinase (BTK) inhibitor for treatment of Waldenstrom macroglobulinemia. In 2024, this provider wrote 31 Medicare prescriptions for Brukinsa, about 1.3 times the volume of the typical Washington prescriber of this medication (23.6). Medicare paid an average of $15,027.17 per fill, versus $13,179.41 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 26 | $24.09▼ below WA avg | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 26 Medicare prescriptions for Tamoxifen Citrate, about 74% of the volume of the typical Washington prescriber of this medication (35.4). Medicare paid an average of $24.09 per fill, versus $25.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 58 30-Day Fills standardized to 30-day supplies 1,740 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 24 | $11.64▼ below WA avg | ≈ Typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 24 Medicare prescriptions for Ondansetron Odt, about the same volume as the typical Washington prescriber of this medication (26). Medicare paid an average of $11.64 per fill, versus $15.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 24 30-Day Fills standardized to 30-day supplies 314 Days of Medication total across all patients in 2024 | |||
| Abiraterone Acetate | 23 | $176.45▼ below WA avg | ▼ Less than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2024, this provider wrote 23 Medicare prescriptions for Abiraterone Acetate, about half the volume of the typical Washington prescriber of this medication (54.2). Medicare paid an average of $176.45 per fill, versus $1,225.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 22 | $1,067.00 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 22 Medicare prescriptions for Eliquis, about a third of the volume of the typical Washington prescriber of this medication (67). Medicare paid an average of $1,067.00 per fill, versus $994.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38.8 30-Day Fills standardized to 30-day supplies 1,136 Days of Medication total across all patients in 2024 | |||
| Imatinib Mesylate | 17 | $618.14▼ below WA avg | ≈ Typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2024, this provider wrote 17 Medicare prescriptions for Imatinib Mesylate, about 87% of the volume of the typical Washington prescriber of this medication (19.5). Medicare paid an average of $618.14 per fill, versus $896.74 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 21 30-Day Fills standardized to 30-day supplies 630 Days of Medication total across all patients in 2024 | |||
| Levothyroxine Sodium | 16 | $9.13▼ below WA avg | ▼ Less than typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 16 Medicare prescriptions for Levothyroxine Sodium, about 14% of the volume of the typical Washington prescriber of this medication (115.6). Medicare paid an average of $9.13 per fill, versus $11.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| Mirtazapine | 15 | $7.05▼ below WA avg | ▼ Less than typical |
About Mirtazapine: This medication is used to treat depression. Show more ▾ Mirtazapine works by helping to restore the balance of certain natural substances in the brain. A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders. In 2024, this provider wrote 15 Medicare prescriptions for Mirtazapine, about half the volume of the typical Washington prescriber of this medication (35.3). Medicare paid an average of $7.05 per fill, versus $22.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 25 30-Day Fills standardized to 30-day supplies 733 Days of Medication total across all patients in 2024 | |||
| Lenalidomide | 15 | $11,594.10▼ below WA avg | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2024, this provider wrote 15 Medicare prescriptions for Lenalidomide, about half the volume of the typical Washington prescriber of this medication (27.7). Medicare paid an average of $11,594.10 per fill, versus $12,983.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| XtandiEnzalutamide | 15 | $12,515.17▼ below WA avg | ▼ Less than typical |
About Xtandi: Enzalutamide is used to treat prostate cancer. Show more ▾ This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer. An antineoplastic agent. In 2024, this provider wrote 15 Medicare prescriptions for Xtandi, about half the volume of the typical Washington prescriber of this medication (28.4). Medicare paid an average of $12,515.17 per fill, versus $13,675.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Letrozole | 14 | $24.67 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 14 Medicare prescriptions for Letrozole, about a quarter of the volume of the typical Washington prescriber of this medication (50.4). Medicare paid an average of $24.67 per fill, versus $22.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2024 | |||
| CreonLipase/Protease/Amylase | 13 | $2,276.00 | ▼ Less than typical |
About Creon: This medication contains digestive enzymes to help break down and digest fats, starch, and proteins in food. Show more ▾ It is used in conditions where the pancreas cannot make or does not release enough digestive enzymes into the small intestines to digest the food (conditions such as chronic pancreatitis, cystic fibrosis, cancer of the pancreas, post-pancreatectomy, post-gastrointestinal bypass surgery). A preparation of hog pancreatic enzymes standardized for lipase content. In 2024, this provider wrote 13 Medicare prescriptions for Creon, about half the volume of the typical Washington prescriber of this medication (29.9). Medicare paid an average of $2,276.00 per fill, versus $1,925.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 280 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl ErMetformin Hcl | 12 | $12.82 | ▼ Less than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 12 Medicare prescriptions for Metformin Hcl Er, about a quarter of the volume of the typical Washington prescriber of this medication (51.2). Medicare paid an average of $12.82 per fill, versus $10.77 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 268 Days of Medication total across all patients in 2024 | |||
| Amlodipine Besylate | 12 | $1.79▼ below WA avg | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2024, this provider wrote 12 Medicare prescriptions for Amlodipine Besylate, about 11% of the volume of the typical Washington prescriber of this medication (106). Medicare paid an average of $1.79 per fill, versus $7.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 24.5 30-Day Fills standardized to 30-day supplies 735 Days of Medication total across all patients in 2024 | |||
| Omeprazole | 11 | $18.24 | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2024, this provider wrote 11 Medicare prescriptions for Omeprazole, about 14% of the volume of the typical Washington prescriber of this medication (78.2). Medicare paid an average of $18.24 per fill, versus $15.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 374 Days of Medication total across all patients in 2024 | |||
| MethotrexateMethotrexate Sodium | 11 | $14.21▼ below WA avg | ▼ Less than typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma), severe psoriasis that has not responded to other treatments, or rheumatoid arthritis. Show more ▾ It may also be used to treat a certain type of arthritis in children (polyarticular juvenile idiopathic arthritis - pJIA). Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and blocking the immune system from attacking healthy tissue. Early treatment of rheumatoid arthritis with methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2024, this provider wrote 11 Medicare prescriptions for Methotrexate, about 12% of the volume of the typical Washington prescriber of this medication (89.1). Medicare paid an average of $14.21 per fill, versus $23.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 27.3 30-Day Fills standardized to 30-day supplies 816 Days of Medication total across all patients in 2024 | |||
| Oxycodone Hcl | 11 | $9.22▼ below WA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 11 Medicare prescriptions for Oxycodone Hcl, about a quarter of the volume of the typical Washington prescriber of this medication (50.3). Medicare paid an average of $9.22 per fill, versus $14.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 11 30-Day Fills standardized to 30-day supplies 147 Days of Medication total across all patients in 2024 | |||
| AlunbrigBrigatinib | 11 | $40,048.21 | – No State Data |
About Alunbrig: Brigatinib is used to treat a certain type of lung cancer (non-small cell lung cancer). Show more ▾ It works by slowing or stopping the growth of cancer cells. An anaplastic lymphoma kinase inhibitor. In 2024, this provider wrote 11 Medicare prescriptions for Alunbrig. Medicare paid an average of $40,048.21 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $40,048.21 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| JakafiRuxolitinib Phosphate | 11 | $12,719.05▼ below WA avg | ▼ Less than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2024, this provider wrote 11 Medicare prescriptions for Jakafi, about a third of the volume of the typical Washington prescriber of this medication (26.8). Medicare paid an average of $12,719.05 per fill, versus $15,834.18 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| Famotidine | 11 | $6.13▼ below WA avg | ▼ Less than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2024, this provider wrote 11 Medicare prescriptions for Famotidine, about a third of the volume of the typical Washington prescriber of this medication (38.8). Medicare paid an average of $6.13 per fill, versus $16.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the WA average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
| Zolpidem Tartrate | 11 | $10.66 | ▼ Less than typical |
About Zolpidem Tartrate: Zolpidem is used for a short time to treat a certain sleep problem (insomnia) in adults. Show more ▾ If you have trouble falling asleep, it helps you fall asleep faster, so you can get a better night's rest. Zolpidem belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA. In 2024, this provider wrote 11 Medicare prescriptions for Zolpidem Tartrate, about a third of the volume of the typical Washington prescriber of this medication (34.1). Medicare paid an average of $10.66 per fill, versus $7.22 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for ALEXANDER ROBINWEILER P.A. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Bellevue, WA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among WA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
